World Health Organization : Year 1993 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 93.114: Report of the WHO Working Group Meeting on Toxopiasmosxs Vaccine Development and Technology

By Marie-France Cesbron

Book Id: WPLBN0000098269
Format Type: PDF eBook:
File Size: 0.3 MB
Reproduction Date: 2005

Title:	World Health Organization : Year 1993 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 93.114: Report of the WHO Working Group Meeting on Toxopiasmosxs Vaccine Development and Technology
Author:	Marie-France Cesbron
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago France Cesbron, B. M. (n.d.). World Health Organization : Year 1993 : Communicable Diseases and Emerging Infectious Diseases ; Vph, No. 93.114. Retrieved from http://gutenberg.cc/

Description
Medical Reference Publication

Excerpt
INTRODUCTION Dr T. Fujikura, Veterinary Public Health, bivision of Communicable Diseases, welcomed the participants (Annex I), and opened the meeting on behalf of the Director-General of WHO. He explained the purpose and scope of the meeting 8s follows: to review the public health significance of toxoplasmosis; to discuss the results of research on toxoplasmosis vaccine development, with particular reference to immunology, antigenic components for vaccine development, animal models and biological requirements of a vaccine ;

Table of Contents
CONTENTS INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . 2 1. PUBLIC HEALTH SIGNIFICANCE OF TOXOPLASMOSLS VACCINE DWEWPMENT . . . . . . . . . . . * . . . . . . . . 2. PARASITE ANTIGENIC COMPLEX FOR VACCINE DEVELOPMENT . . . . 2 3. CELL-MEDIATED I W E RESPONSE TO A VACCINE . . . . . . . . 3 4. ANIMAL MODELS, CHALLENGE STRAINS, LEVELS AND TYPES OF IMMUNE PROTECTION REQUIRED . . . . . . . . . . . . . . . . 4 4.1 Animal models . . . . . . . . . . . . . . . . . . . . 4 4.2 Challenge s t r a i n s . . . . . . . . , . . . . . . . . . 7 4.3 Levels and types o f p r o t e c t i o n r e q u i r e d . . . . . . . 7 4.L Genetics . . . . . . . . . . . . . . . . . . . . . . . 8 5. PUNNING AND MANAGEMENT OF FIELD VACCINATION TRIALS . . . . 8 6 . UORK PLANS FOR 1992-1994 . . . . . . . . . . . . . . . . . 8 7. CONCLUSIONS AND RECOMMENDATIONS . . . . . . . . . . . . . . 9 7.1 Conclusions . . . . . . . . . . . . . . . . . . . . . 9 7.2 Recommendations . . . . . . . . . . . . . . . . . . . . 9 ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . , . . . . . . . 10 ANNEX I. L i s t of p a r t i c i p a n t s . . . . . . . . . . . . . . . . . 11